Pure Global

๐Ÿ‡ง๐Ÿ‡ทBrazil Medical Device Regulations

Agรชncia Nacional de Vigilรขncia Sanitรกria (ANVISA)

16 Regulations
8 Categories
Filters

Showing 1-10 of 16 regulations

๐Ÿ‡ง๐Ÿ‡ท

RDC 925/2024

Registration

Medical Device Sanitary Control and Import Procedures

Requirements for import licenses, customs clearance, and regulatory compliance for medical devices imported into Brazil.

ANVISA (Brazil)Effective: January 2, 2025Doc: Portuguese
๐Ÿ‡ง๐Ÿ‡ท

RDC 848/2024

Registration

Medical Device Regularization and Compliance

Requirements for medical device regularization, quality management, technical documentation, and post-market surveillance.

ANVISA (Brazil)Effective: December 2, 2024Doc: Portuguese
๐Ÿ‡ง๐Ÿ‡ท

IN 290/2024

Registration

Leveraging Foreign Regulatory Authorizations (AREE)

Streamlines evaluation for Class III/IV devices already approved by GHTF founding members (USA FDA, Canada, Japan, Australia TGA). Estimated 30% reduction in ANVISA review time.

ANVISA (Brazil)Effective: June 3, 2024Doc: Portuguese
๐Ÿ‡ง๐Ÿ‡ท

RDC 830/2023

IVD

In Vitro Diagnostic (IVD) Medical Devices

Regulation for IVD medical devices including classification (Class I-IV), registration pathways, self-testing requirements, and companion diagnostics. Replaced RDC 36/2015.

ANVISA (Brazil)Effective: June 1, 2024Doc: English
๐Ÿ‡ง๐Ÿ‡ท

RDC 884/2024

UDI

UDI Implementation Timeline Extension

Amends RDC 591/2021 extending UDI deadlines by one year. Class IV: July 2025, Class III: January 2026, Class II: January 2027, Class I: January 2028.

ANVISA (Brazil)Effective: June 1, 2024Doc: Portuguese
๐Ÿ‡ง๐Ÿ‡ท

RDC 850/2024

GMP/QMS

GMP Certificate Extension for MDSAP Manufacturers

Extends B-GMP certificates from 2 to 4 years for manufacturers with MDSAP certificates. Amends RDC 497/2021. Reduces regulatory costs and ANVISA inspection burden.

ANVISA (Brazil)Effective: April 1, 2024Doc: Portuguese
๐Ÿ‡ง๐Ÿ‡ท

RDC 837/2023

Clinical Trials

Clinical Studies Guidelines for Medical Devices

Establishes guidelines for clinical studies conducted within Brazil for medical devices. Defines requirements for clinical investigation protocols and ethical approvals.

ANVISA (Brazil)Effective: December 2023Doc: Portuguese
๐Ÿ‡ง๐Ÿ‡ท

RDC 751/2022

Classification

Medical Device Registration and Classification

Core regulation for medical device classification (Class I-IV) and registration pathways (notification vs. marketing authorization) in Brazil.

ANVISA (Brazil)Effective: March 1, 2023Doc: English
๐Ÿ‡ง๐Ÿ‡ท

RDC 665/2022

GMP/QMS

Good Manufacturing Practice (GMP) for Medical Devices

GMP requirements for medical device manufacturers including quality management system, design controls, and production processes. Replaced RDC 16/2013.

ANVISA (Brazil)Effective: May 2, 2022Doc: English
๐Ÿ‡ง๐Ÿ‡ท

RDC 591/2021

UDI

Unique Device Identification (UDI) System

Brazil's UDI system requiring unique identifiers, barcode labels, and GUDID database submission for improved device traceability.

ANVISA (Brazil)Effective: Phased 2022-2026Doc: Portuguese
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing